Compare Inovio Pharmaceuticals Inc (INO) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs US Bancorp — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while US Bancorp trades at $64.34 (market cap $100.17B). The key difference: US Bancorp is far larger — about 1275.2× Inovio Pharmaceuticals Inc's market cap, and US Bancorp pays a 3.24% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | USB | |
|---|---|---|
Market Cap | $78.55M | $100.17B |
Sector | Health | Financials |
52-Week High | $2.87 | $64.47 |
52-Week Low | $0.66 | $45.28 |
Enterprise Value | $49.56M | — |
Dividend Yield | — | 3.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
